Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues...
Maintenance of optimal gene expression levels is critical for cell viability and homeostasis. Howeve...
Hsp104 is a hexameric AAA+ yeast disaggregase capable of solubilizing disordered aggregates and amyl...
There is currently no cure for neurodegenerative disease or the underlying burden of protein aggrega...
Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autore...
Hsp104, a protein disaggregase from yeast, can be engineered and potentiated to counter TDP-43, FUS,...
Hsp104 is a AAA+ protein disaggregase found in yeast that employs energy from ATP hydrolysis to disa...
Hsp104 is a AAA+ protein disaggregase found in yeast that employs energy from ATP hydrolysis to disa...
Potentiated variants of Hsp104, a protein disaggregase from yeast, can dissolve protein aggregates c...
The AAA+ protein disaggregase, Hsp104, increases fitness under stress by reversing stress-induced pr...
l o single residues in helix 1, 2, or 3 of the middle domain oligomers (DeSantis et al., 2012; Lo Bi...
Protein aggregation is a biochemical hallmark of fatal neurodegenerative disease. Protein disaggrega...
Protein misfolding is implicated in numerous lethal neurodegenerative disorders, including amyotroph...
Protein aggregation is a hallmark of neurodegenerative disease where the accumulation of insoluble p...
Maintenance of optimal gene expression levels is critical for cell viability and homeostasis. Howeve...
There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpi...
Maintenance of optimal gene expression levels is critical for cell viability and homeostasis. Howeve...
Hsp104 is a hexameric AAA+ yeast disaggregase capable of solubilizing disordered aggregates and amyl...
There is currently no cure for neurodegenerative disease or the underlying burden of protein aggrega...
Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autore...
Hsp104, a protein disaggregase from yeast, can be engineered and potentiated to counter TDP-43, FUS,...
Hsp104 is a AAA+ protein disaggregase found in yeast that employs energy from ATP hydrolysis to disa...
Hsp104 is a AAA+ protein disaggregase found in yeast that employs energy from ATP hydrolysis to disa...
Potentiated variants of Hsp104, a protein disaggregase from yeast, can dissolve protein aggregates c...
The AAA+ protein disaggregase, Hsp104, increases fitness under stress by reversing stress-induced pr...
l o single residues in helix 1, 2, or 3 of the middle domain oligomers (DeSantis et al., 2012; Lo Bi...
Protein aggregation is a biochemical hallmark of fatal neurodegenerative disease. Protein disaggrega...
Protein misfolding is implicated in numerous lethal neurodegenerative disorders, including amyotroph...
Protein aggregation is a hallmark of neurodegenerative disease where the accumulation of insoluble p...
Maintenance of optimal gene expression levels is critical for cell viability and homeostasis. Howeve...
There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpi...
Maintenance of optimal gene expression levels is critical for cell viability and homeostasis. Howeve...
Hsp104 is a hexameric AAA+ yeast disaggregase capable of solubilizing disordered aggregates and amyl...
There is currently no cure for neurodegenerative disease or the underlying burden of protein aggrega...